KCM
SPHS

Kathmere Capital Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Kathmere Capital Management’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,150
Closed -$4K – 125
2019
Q4 		$4K Buy
+10,150
New +$4.61K ﹤0.01% 118

Other funds holding SPHS

HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
ACM
AUA Capital Management Camp Hill, Pennsylvania $216M AUM 19.17% 1-Year Est. Return

Kathmere Capital Management's SPHS Position: Q1 2020 in Review

Kathmere Capital Management sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 10,150 shares — an estimated $4K sold.

Kathmere Capital Management first reported a position in SPHS in Q4 2019 and held it in 1 quarter. The position peaked at $4K in Q4 2019. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

  • Kathmere Capital Management reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
  • Kathmere Capital Management sold 10,150 Sophiris Bio, Inc. shares in Q1 2020, an estimated $4K.
  • Kathmere Capital Management first reported a position in Sophiris Bio, Inc. in Q4 2019 and held it in 1 quarter.
  • Kathmere Capital Management's Sophiris Bio, Inc. position peaked at $4K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Kathmere Capital Management's 13F filing for Q1 2020, filed 6 May 2020.